▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3879 by analyst upside · 2026-06-27
AVTR
Avantor, Inc.
Healthcare · Market Cap $7B · P/E 0x
ANALYST PRICE TARGET
-5.3%
implied upside to consensus target
Current Price $10.28
Consensus Target $9.73
Bull Target $19.0
Bear Target $7.0
Analysts Covering 15
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
11
Sell
1
52-Week Low $7.26
52-Week High $15.93
YTD Return -10.3%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) N/A
Forward P/E 12.1x
EPS (TTM) $-0.81
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $6.6B
Profit Margin -8.4%
52-WEEK RANGE
52-Week Low $7.26
52-Week High $15.93
Current Price $10.28
Bear Target $7.0
Bull Target $19.0
● Now $10.28 ● Target $9.73
TRADING DATA
Avg Volume 9.4M
YTD Return -10.3%
Analyst Count 15
Consensus Hold
Upside to Target -5.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Avantor, Inc. (AVTR) is currently trading at $10.28 with a Wall Street consensus price target of $9.73, which is 5.3% below the current price over the next 12 months. 15 analysts currently cover AVTR, with a consensus rating of Hold - 20% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $7.0.

AVTR operates in the Healthcare sector with a market capitalisation of $7B. The stock is down 10.3% year-to-date and is currently trading near the lower end of its 52-week range of $7.26 – $15.93.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

LNTH -4.2%
Lantheus Holdings, Inc.
$7B · P/E 26.0x · Buy
CHE -3.6%
Chemed Corporation
$6B · P/E 24.7x · Hold
TGTX -7.4%
TG Therapeutics, Inc.
$9B · P/E 19.5x · Buy
QGEN +11.6%
Qiagen N.V.
$8B · P/E 20.1x · Buy
PACS +18.6%
PACS Group, Inc.
$7B · P/E 27.0x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AVTR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup — Reiterated
Neutral → Neutral 2026-04-30 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-30 Building track record
Barclays — Reiterated
Underweight → Underweight 2026-04-15 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-06 Building track record
Barclays ↓ Downgrade
Equal-Weight → Underweight 2026-03-06 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-02-13 Building track record
Citigroup — Reiterated
Neutral → Neutral 2026-02-12 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-02-12 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
30
out of 100
Coverage depth
21/30
Consensus clarity
7/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →